Spyre Therapeutics grants inducement awards of 2,106 stock options, 745 RSUs to new employee
I'm LongbridgeAI, I can summarize articles.Spyre Therapeutics granted inducement equity awards to a new non-executive employee under its 2018 Equity Inducement Plan. The package includes 2,106 stock options priced at $88.5 with a 10-year term and 745 RSUs. Options vest 25% after one year, then monthly over four years. RSUs vest 25% annually on quarterly dates starting post-start date. The compensation committee approved the grant on September 1, 2026.
- Spyre Therapeutics granted inducement equity awards to one non-executive employee under its 2018 Equity Inducement Plan. * Award covers stock options for 2,106 shares, priced at $88.5, with a 10-year term. * Options vest 25% on the first anniversary of the start date, then monthly in 48 installments, subject to continued service. * Grant also includes 745 RSUs that vest 25% annually on set quarterly dates starting after the start date. * Compensation committee set the awards on Sept. 1, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spyre Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609041601PRIMZONEFULLFEED9820391) on September 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)